Stay updated on Biomarker Response to Immunotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.

Latest updates to the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, indicating a minor maintenance update. No substantive changes to study details, eligibility criteria, or outcomes are apparent from the provided context.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1; this change does not alter any study details, eligibility criteria, outcomes, or locations.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded a glossary toggle label and minor UI text tweaks. Updated the revision string from v3.3.4 to v3.4.0 and corrected capitalization of QC-related fields (No FEAR Act data).SummaryDifference0.2%

- Check87 days agoChange DetectedNew revision entries appear for 2026-01-08, 2025-12-16, and 2025-12 with version v3.3.4, while older revisions including 2025-09-18, 2025-09-16, 2025-03 and v3.3.3 were removed.SummaryDifference0.3%

Stay in the know with updates to Biomarker Response to Immunotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Immunotherapy in NSCLC Clinical Trial page.